False-positive anti-PLA2R ELISA testing in patients with diabetes mellitus.

作者信息

Caza Tiffany N, Larsen Christopher P

机构信息

Arkana Laboratories, Little Rock, Arkansas, USA.

出版信息

Kidney Int. 2023 Feb;103(2):425. doi: 10.1016/j.kint.2022.11.004.

DOI:10.1016/j.kint.2022.11.004

PMID:36681457

Abstract

摘要

相似文献

[1]

False-positive anti-PLA2R ELISA testing in patients with diabetes mellitus.

Kidney Int. 2023-2

[2]

Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience.

J Nephrol. 2021-4

[3]

Comparison of measurements of anti-PLA2R antibodies in Japanese patients with membranous nephropathy using in-house and commercial ELISA.

Clin Exp Nephrol. 2019-4

[4]

Definition of a new cut-off for the anti-phospholipase A2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy.

J Nephrol. 2018-9-5

[5]

Validation of phospholipase A receptor direct immunofluorescence staining in the diagnosis of primary membranous glomerulonephritis.

Pathology. 2020-8

[6]

[Clinical application of homemade ELISA kit for anti-human phospholipase A2 receptor antibody].

Sheng Wu Gong Cheng Xue Bao. 2018-5-25

[7]

M-Type Phospholipase A2 Receptor Autoantibody Measured by ELISA has Diagnostic Value in Patients with Idiopathic Membranous Nephropathy.

Clin Lab. 2023-6-1

[8]

Serum anti-PLA2R antibody as a diagnostic biomarker of idiopathic membranous nephropathy: The optimal cut-off value for Chinese patients.

Clin Chim Acta. 2017-11-7

[9]

Anti-PLA2R Antibodies in Chinese Patients with Membranous Nephropathy.

Med Sci Monit. 2016-5-15

[10]

PLA2R and membranous nephropathy: A 3 year prospective Australian study.

Nephrology (Carlton). 2016-5

引用本文的文献

[1]

Targeting the Optimal Antibody Strategy for a Noninvasive Diagnosis of Phospholipase A2 Receptor-Associated Membranous Nephropathy: Is Serology Alone Sufficient?

Clin J Am Soc Nephrol. 2025-5-1

[2]

Noninvasive Diagnostic Strategies for Membranous Nephropathy in the Nephrotic Syndrome Study Network.

Clin J Am Soc Nephrol. 2025-5-1

[3]

PLA2R autoantibodies, a multifaceted biomarker in nephrotic syndrome and membranous nephropathy.

Nephrol Dial Transplant. 2025-8-1

[4]

The Significance of Anti-PLA2R in Diabetic Kidney Disease: Truly a False Positive?

Glomerular Dis. 2024-4-20

[5]

Anti-GBM antibody in a patient with diabetic nephropathy; all that glitters is not gold.

J Nephrol. 2024-11

[6]

Significance of the total renal chronicity score in predicting renal outcome in PLA2R-associated membranous nephropathy.

J Nephrol. 2024-5

[7]

Novel biomarkers and pathophysiology of membranous nephropathy: PLA2R and beyond.

Clin Kidney J. 2023-12-11

[8]

The Role of PLA2R in Primary Membranous Nephropathy: Do We Still Need a Kidney Biopsy?

Genes (Basel). 2023-6-26

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

False-positive anti-PLA2R ELISA testing in patients with diabetes mellitus.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献